Literature DB >> 24898048

A biotin-guided fluorescent-peptide drug delivery system for cancer treatment.

Taeyoung Kim1, Hyun Mi Jeon, Hoa Thi Le, Tae Woo Kim, Chulhun Kang, Jong Seung Kim.   

Abstract

Herein, we present a fluorescent-peptide drug delivery system composed of biotin-naphthalimide-HJ inhibitor peptide2, prodrug 1. Treatment of 1 to biotin receptor-positive HepG2 cells, which are resistant to high concentrations of the HJ inhibitor peptide2, decreased cell viability and increased intracellular fluorescence.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24898048     DOI： 10.1039/c4cc02878c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

1.  A biotin-guided hydrogen sulfide fluorescent probe and its application in living cell imaging.

Authors:  Chen Zhang; Jiewen Zhang; Zhiqiang Xu; Kun Zang; Feng Liu; Jun Yin; Ying Tan; Yuyang Jiang
Journal:  RSC Adv       Date:  2020-10-01       Impact factor: 4.036

Review 2.  Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics.

Authors:  Min Hee Lee; Amit Sharma; Min Jung Chang; Jinju Lee; Subin Son; Jonathan L Sessler; Chulhun Kang; Jong Seung Kim
Journal:  Chem Soc Rev       Date:  2018-01-02       Impact factor: 54.564

Review 3.  Disulfide based prodrugs for cancer therapy.

Authors:  Qiang Wang; Jiankun Guan; Jiangling Wan; Zifu Li
Journal:  RSC Adv       Date:  2020-06-25       Impact factor: 4.036

4.  Solid-phase fluorescent BODIPY-peptide synthesis via in situ dipyrrin construction.

Authors:  Yue Wu; Wing-Sze Tam; Ho-Fai Chau; Simranjeet Kaur; Waygen Thor; Wei Shen Aik; Wai-Lun Chan; Markus Zweckstetter; Ka-Leung Wong
Journal:  Chem Sci       Date:  2020-09-24       Impact factor: 9.825
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.